Table 2.
Disorder | Natural Remedies | Compounds | Model | Finding | Mode of Action | Reference |
---|---|---|---|---|---|---|
Medicinal plant | ||||||
SCA3 |
Rehmannia glutinosa
|
Catalpol | HEK-293 and SH-SY5Y cells | Promoted proteasome activity, suppressed polyQ aggregation, prevented cell death | UPS | [55] |
Pueraria lobate
|
Puerarin and daidzein | iPSCs | Promoted proteasome activity, suppressed polyQ aggregation, prevented cell death | [56] | ||
Gastrodia elata
|
T1-11 and JMF-1907 | Mice | Promoted proteasome activity, prevented cell death, restored motor function | [57] | ||
Gardenia jasminoides
|
Genipin, geniposide and crocin | HEK-293 and SH-SY5Y cells | Promoted the expression of antioxidant genes, suppressed ROS level | NRF2 signalling pathway | [58] | |
Glycyrrhiza inflata
|
Licochalcone A and AMGZ | Promoted the expression of antioxidant genes, suppressed ROS level, suppressed polyQ aggregation | [59] | |||
Paeonia lactiflora
|
Paeoniflorin | Promoted expression of heat shock proteins, suppressed polyQ aggregation, restored motor function | N/A | [60] | ||
Brassica napus
|
Sinapine | Roundworm | Promoted expression of antioxidant genes, suppressed ROS level, restored motor function | N/A | [61] | |
SCA17 |
Ginkgo biloba
|
N/A | SH-SY5Y cells and mice | Prevented calcium influx, prevented cell death | Calcium homeostasis | [62] |
Herbal formulation | ||||||
SCA6 | Zhengan Xifeng Tang | N/A | Human | Restored motor function | N/A | [63, 64] |
SCA17 | Shaoyao Gancao Tang | N/A | HEK-293 and SH-SY5Y cells | Promoted expression of antioxidant genes, prevented cell death, restored mitochondrial biogenesis, restored motor function | N/A | [65] |
Medicinal mushroom | ||||||
FRDA |
Hericium erinaceus
|
N/A | Fibroblast | Prevented antioxidant depletion, prevented cell death | N/A | [66] |
SCA spinocerebellar ataxia, HEK-293 human embryonic kidney 293 cells, UPS ubiquitin–proteasome system, iPSCs induced-pluripotent stem cells, T1-11, N6-(4-Hydroxybenzyl) adenosine; JMF-1907, N6-(3-Indolylethyl) adenosine; NRF2 nuclear factor erythroid 2–related factor 2; AMGZ ammonium glycyrrhizinate; FRDA Friedreich’s ataxia; N/A not applicable